Abstract
The aim of the present study was to determine the prevalence of human leukocyte antigen HLA-B27 in Moroccan healthy controls and in patients with ankylosing spondylitis (AS), and to analyze the correlation between HLA-B27 and AS in Moroccan patients. The prevalence of HLA-B27 was determined by evaluating the number of HLA-B27-positive samples in 128 healthy subjects and in 53 patients diagnosed with AS according to the ESSG and AMOR criteria. HLA-B27 was determined by the polymerase chain reaction using sequence-specific primers. Multivariate analysis of our data (HLA-B27, age, sex, and family history) for AS and healthy controls was performed by multiple correspondence analysis (MCA). The frequency of HLA-B27 was significantly greater in AS patients (45.3 %) than in healthy controls (4.7 %) [p < 0.0001, OR 16.8, and CI 95 % (5.83–51.03)]. In addition, HLA-B27 was more common in male patients than in female ones (p < 0.05). 100 % of the AS patients reported a family history of AS, whereas only 20 % of the healthy controls reported a family history of AS. The graphical interpretation of MCA showed a significant relation between the presence of HLA-B27 and AS. This study strengthens the link between HLA-B27 and AS and represents a very valuable informative diagnostic tool, especially in regard to male patients who have a family history of AS.
Similar content being viewed by others
References
Akgul O, Ozgocmen S (2011) Classification criteria for spondyloarthropathies. World J Orthop 2:107–115
Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A et al (1998) Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58–67
Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15–25
Dean LE, Jones GT, Macdonald AG, Downham C, Sturrock RD, Macfarlane GJ (2014) Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 53:650–657
Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288:704–706
Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock R (1973) Ankylosing spondylitis and HL-A27. Lancet 1:904–907
Brown MA (2008) Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology (Oxford) 47:132–137
Khan MA, Mathieu A, Sorrentino R, Akkoc N (2007) The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev 6:183–189
Ebringer A (1983) The cross-tolerance hypothesis, HLA B27 and ankylosing spondylitis. Br J Rheumatol 22(suppl 2):53–66
Mear JP, Schreiber KL, Münz C, Zhu X, Stevanović S, Rammensee HG et al (1999) Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol 163:6665–6670
Blanco-Gelaz MA, López-Vázquez A, García-Fernández S, Martínez-Borra J, González S, López-Larrea C (2001) Genetic variability, molecular evolution, and geographic diversity of HLA-B27. Hum Immunol 62:1042–1050
Mijiyawa M, Oniankitan O, Khan MA (2000) Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 12:281–286
Khan MA, Ball EJ (2002) Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 16:675–690
Reveille JD, Arnett FC (2005) Spondyloarthritis: update on pathogenesis and management. Am J Med 118:592–603
Reveille JD (2006) Major histocompatibility genes and ankylosing spondylitis. Best Pract Res Clin Rheumatol 20:601–609
Gómez-Casado E, del Moral P, Martínez-Laso J, García-Gómez A, Allende L, Silvera-Redondo C et al (2000) HLA genes in Arabic-speaking Moroccans: close relatedness to Berbers and Iberians. Tissue Antigens 55:239–249
Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D, Stylianou G, Kokkofitou A, Michalis C et al (2004) HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B2707. Hum Immunol 65:1451–1454
Kchir MM, Hamdi W, Laadhar L, Kochbati S, Kaffel D, Saadellaoui K et al (2010) HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study). Rheumatol Int 30:933–939
Ayed K, Ayed-Jendoubi S, Sfar I, Labonne MP, Gebuhrer L (2004) HLA class-I and HLA class-II phenotypic, gene and haplotypic frequencies in Tunisians by using molecular typing data. Tissue Antigens 64:520–532
Al-Attia HM, Al-Amiri N (1995) HLA-B27 in healthy adults in UAE. An extremely low prevalence in Emirian Arabs. Scand J Rheumatol 24:225–227
Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European spondyloarthropathy study group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34:1218–1227
Amor B, Dougados M, Mujiyawa M (1990) Critères diagnostiques des spondylarthropathies. Rev Rhum 57:85–89
Olerup O (1994) HLA-B27 typing by a group-specific PCR amplification. Tissue Antigens 43:253
Benzecri JP (1973) Analyses des Données. Dunod, Paris, pp 1–2
Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(Suppl 3):iii8–iii18
Liu X, Li YR, Hu LH, Zhou ZM, Chen FH, Ning Y et al (2010) High frequencies of HLA-B27 in Chinese patients with suspected of ankylosing spondylitis. Rheumatol Int 30:1305–1309
Gunal EK, Sarvan FO, Kamali S, Gul A, Inanc M, Carin M et al (2008) Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey. Joint Bone Spine 75:299–302
Woodrow JC, Nichol FE, Whitehouse GH (1983) Genetic studies in ankylosing spondylitis. Br J Rheumatol 22(suppl 2):12–17
Tsui FWL, Haroon N, Reveille JD, Rahman P, Chiu B, Tsui HW et al (2010) Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis 69:733–736
Baek HJ, Shin KC, Lee YJ, Kang SW, Lee EB, Yoo CD et al (2004) Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. Rheumatology (Oxford) 43:1526
Frikha F, Marzouk S, Jallouli M, Frigui M, Kaddour N, Jribi S et al (2006) La spondylarthrite ankylosante: étude d’une série de 83 cas. Revue du rhumatisme 73:1251
Atouf O, Benbouazza K, Brick C, Saoud B, Benseffaj N, Amine B et al (2012) Distribution of HLA class I and II genes in ankylosing spondylitis patients from Morocco. Pathol Biol 60:e80–e83
López de Castro JA (2007) HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 108:27–33
Acknowledgments
The current study was supported by Mohammed V-Agdal University “plan d’urgence” research grant. We would like to thank all patients and healthy controls for their participation. We are sincerely grateful to the clinicians and nurses for their contribution to the clinical examinations and blood collection. The authors wish to express their gratitude to Denis Groleau, Professor at Chemical and Biotechnological engineering department, Faculté de Génie, University of Sherbrooke, for his help in this study and Mounia Akassou for computing assistance.
Authors’ contributions
All authors contributed to the conduct of the research and writing of this manuscript. Authors reviewed and approved the final version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no conflict of interest exists.
Rights and permissions
About this article
Cite this article
Akassou, A., Yacoubi, H., Jamil, A. et al. Prevalence of HLA-B27 in Moroccan healthy subjects and patients with ankylosing spondylitis and mapping construction of several factors influencing AS diagnosis by using multiple correspondence analysis. Rheumatol Int 35, 1889–1894 (2015). https://doi.org/10.1007/s00296-015-3342-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-015-3342-x